Head of the Prescription Global Business Unit
Thibaud Portal has been Head of the Prescription Global Business Unit since 2015.
Thibaud is responsible for the definition and execution of the long-term strategy in Prescription. He oversees the creation and development of the project pipeline, the value proposition of all assets in Prescription and the value enhancement of the portfolio of prescription products marketed by Galderma worldwide. He also manages teams in the Global Marketing, Market Access, Value and Economics, Business Development, Medical Affairs and Phase IV, Basic and Applied Research, Regulatory Affairs and Development functions, in Switzerland and in the U.S. Since joining this new role, he has led a wide ranging transformation of this business within Galderma.
Thibaud joined Galderma in 1997 as a researcher in Chemistry at the Sophia Antipolis R&D center, France. He became R&D Project Leader and then headed the Research & Chemical Development department from 2010 to 2013. This experience, which included leading the integration of the Spirig and Q-Med R&D organizations, allowed him to gain broad expertise in R&D. In 2013, Thibaud was appointed Director of the Global R&D Portfolio & Project Management, where he managed the active projects in all portfolios (Aesthetics, Prescription, Consumer), and supervised fields of expertise such as Medical Science, Clinical safety and Pharmaceutical Expertise.
Thibaud is French and has an Engineering & Chemical engineering degree from the Ecole Supérieure de Chimie Industrielle, Lyon, France and a PhD in Medicinal Chemistry from Wayne State University, Detroit, U.S. He also carried out Postdoctoral studies at the ISCN-Ecole Polytechnique, Paris, France.